Evidence map›Paper›PMID 36294662›Full record

ReviewJournal of fungi (Basel, Switzerland)2022

Paracoccidioidomycosis: What We Know and What Is New in Epidemiology, Diagnosis, and Treatment.

Paulo Mendes Peçanha, Paula Massaroni Peçanha-Pietrobom, Tânia Regina Grão-Velloso, Marcos Rosa Júnior, Aloísio Falqueto, Sarah Santos Gonçalves

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Telomeric assemblies ofbioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Review
  17. Acute-Subacute Paracoccidioidomycosis.The American journal of tropical medicine and hygiene · 2025
    Article
  18. Review
  19. Antifungal activity of guanidine compounds.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paulo Mendes PeçanhaDepartment of Medical Clinic, Division of Infectious Diseases, Federal University of Espírito Santo (UFES), Vitoria 29043900, Brazil.ORCID 0000-0003-1387-5554
Paula Massaroni Peçanha-PietrobomDepartment of Medicine, Division of Infectious Diseases, Federal University of São Paulo (UNIFESP), São Paulo 04039032, Brazil.
Tânia Regina Grão-VellosoDepartment of Dental Clinic, Federal University of Espírito Santo (UFES), Vitoria 29043900, Brazil.
Marcos Rosa JúniorDepartment of Medical Clinic, Federal University of Espírito Santo (UFES), Vitoria 29043900, Brazil.ORCID 0000-0001-8668-2804
Aloísio FalquetoDepartment of Medical Clinic, Division of Infectious Diseases, Federal University of Espírito Santo (UFES), Vitoria 29043900, Brazil.
Sarah Santos GonçalvesDepartment of Pathology, Infectious Diseases Postgraduate Program, Center for Research in Medical Mycology, Federal University of Espírito Santo (UFES), Vitoria 29043900, Brazil.ORCID 0000-0003-4170-4445
Universidade Federal do Espírito Santo · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paracoccidioidomycosis (PCM) is a systemic mycosis endemic to Latin America caused by thermodimorphic fungi of the genus

Indexed as

endemic mycosisParacoccidioides spp.paracoccidioidomycosisthermodimorphic fungi

Identifiers

PMID36294662
PMCPMC9605487
OpenAlexW4306766605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.